Related Experiment Video

Updated: Apr 28, 2026

Author Spotlight: Developing Tools to Tune the Activity of Tyrosine Phosphatases
06:56

Author Spotlight: Developing Tools to Tune the Activity of Tyrosine Phosphatases

Published on: September 6, 2024

856

The prolyl peptidases PRCP/PREP regulate IRS-1 stability critical for rapamycin-induced feedback activation of PI3K

Lei Duan1, Guoguang Ying2, Brian Danzer3

  • 1From the Department of Anatomy and Cell Biology, Rush University Medical Center, Chicago, Illinois 60612, lduan@rush.edu.

The Journal of Biological Chemistry
|June 18, 2014
PubMed

Insights

Prolylcarboxypeptidase (PRCP) and prolylendopeptidase (PREP) stabilize IRS-1, a key component of the PI3K/AKT/mTOR pathway in pancreatic cancer. Inhibiting PRCP and PREP enhances cancer cell death when combined with rapamycin.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • The PI3K/AKT/mTOR pathway is crucial for cell growth and survival, often dysregulated in cancer.
  • Prolylcarboxypeptidase (PRCP) and prolylendopeptidase (PREP) have been implicated in cancer cell proliferation and survival.

Purpose of the Study:

  • To investigate the role of PRCP and PREP in pancreatic cancer.
  • To elucidate the mechanism by which PRCP and PREP regulate the PI3K/AKT/mTOR pathway.

Main Methods:

  • Depletion and inhibition of PRCP and PREP in pancreatic cancer cells.
  • Analysis of IRS-1 phosphorylation and degradation.
  • Assessment of PI3K and AKT signaling.
  • Evaluation of rapamycin-induced cytotoxicity.

Main Results:

  • PRCP and PREP are essential for pancreatic cancer cell proliferation and survival.
  • Inhibition of PRCP/PREP leads to IRS-1 degradation and PI3K/AKT pathway inactivation.
  • PRCP/PREP inhibition sensitizes pancreatic cancer cells to rapamycin by destabilizing IRS-1 and blocking feedback activation.

Conclusions:

  • PRCP and PREP act as critical stabilizers of IRS-1 in pancreatic cancer.
  • Targeting PRCP and PREP enhances the efficacy of rapamycin therapy by disrupting the PI3K/AKT/mTOR pathway.
Keywords:
Akt PKBApoptosisCancer TherapyCell DeathCell SignalingMammalian Target of Rapamycin (mTOR)Phosphatidylinositide 3-Kinase (PI 3-kinase)

More Related Videos

Identification of Inositol Phosphate or Phosphoinositide Interacting Proteins by Affinity Chromatography Coupled to Western Blot or Mass Spectrometry08:07

Identification of Inositol Phosphate or Phosphoinositide Interacting Proteins by Affinity Chromatography Coupled to Western Blot or Mass Spectrometry

Published on: July 26, 2019

7.9K
Mechanistic Insight into the Development of TNBS-Mediated Intestinal Fibrosis and Evaluating the Inhibitory Effects of Rapamycin10:21

Mechanistic Insight into the Development of TNBS-Mediated Intestinal Fibrosis and Evaluating the Inhibitory Effects of Rapamycin

Published on: September 12, 2019

7.9K

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
10.1K
The Unfolded Protein Response01:37

The Unfolded Protein Response

The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
5.6K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.3K